Pacific BioDevelopment, LLC was founded in 1996 with the mission of providing a range of high quality strategic and integrative services to the biotechnology and pharmaceutical industries.
The development of a prescription drug that gains marketing approval costs an average of
and is often a process that takes more than ten years.
*Source: Deloitte Measuring the return from pharmaceutical innovation – 14th edition 2023
Pacific BioDevelopment consultants cover the full range of drug development to commercialization.
We have over
of experience in the field since we openned in 1996.
We have advised more than
companies worldwide in strategic drug-development.
The development of a prescription drug that gains marketing approval costs an average of $2.3 billion* and is often a process that takes more than ten years.
*Source: Deloitte Measuring the return from pharmaceutical innovation – 14th edition 2023
Pacific BioDevelopment opened its doors for business in 1996. Since then, we have provided strategic drug-development advice to more than 500 companies worldwide.
Pacific BioDevelopment consultants cover the full range of drug development to commercialization.
Early-stage companies have extreme pressure to get drug candidates into the clinic quickly to show initial promise to enable partnering or to gain additional funding.
Mid-sized biotechnology and pharmaceutical companies provide much of the innovation that fuels the medical industry.
Multinational biotechnology and pharmaceutical companies need expertise across global markets and in all aspects of development to ensure they maximize the market potential of their drugs.
© Pacific Biodevelopment 2025, All Rights Reserved.
